Hint mode is switched on Switch off
For swift navigation between sections

Domestic bonds: Bristol Myers Squibb, 5.875% 15nov2036, USD
US110122AP35

Bid / Ask
/
Buy selected bonds via Exante trading platform
BUY / SELL Registration on Cbonds is required
  • Placement amount
    1,250,000,000 USD
  • Outstanding amount
    403,364,000 USD
  • USD equivalent
    403,364,000 USD
  • Denomination
    1,000 USD
  • ISIN
    US110122AP35
  • CFI
    DBFSGR
  • FIGI
    BBG0000FDZ76
  • SEDOL
    B1HLYY4
  • Ticker
    BMY 5.875 11/15/36

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access
×

— Are you looking for complete & verified bond data?

— We have everything
you need:

  • full data on over 700 000 bonds, stocks & ETFs;
  • powerful bond screener;
  • over 350 pricing sources among stock exchanges & OTC market;
  • ratings & financial reports;
  • user-friendly interface;
  • available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 652K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Files

Prospectus

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, ...
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
Show more Hide
Volume
  • Placement amount
    1,250,000,000 USD
  • Outstanding amount
    403,364,000 USD
  • Outstanding face value amount
    403,364,000 USD
Nominal
  • Nominal
    1,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access
×

— Are you looking for complete & verified bond data?

— We have everything
you need:

  • full data on over 700 000 bonds, stocks & ETFs;
  • powerful bond screener;
  • over 350 pricing sources among stock exchanges & OTC market;
  • ratings & financial reports;
  • user-friendly interface;
  • available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 652K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***
  • Depository
    ***

Conversion and exchange

  • Conversion terms
    ***

Covenants

  • Change of Control

    ***

  • Collective Action Clause

    ***

  • Covenant Suspension/Fall-Away

    ***

  • Cross Default

    ***

  • Designation of Restricted and Unrestricted Subsidiaries

    ***

  • Events of Default

    ***

  • Financial Covenants

    ***

  • Limitation on Business Activities

    ***

  • Limitation on Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries

    ***

  • Limitation on Indebtedness

    ***

  • Limitation on Investments

    ***

  • Limitation on Liens

    ***

  • Limitation on Restricted Payments

    ***

  • Limitation on Sale of Assets

    ***

  • Limitation on Sale/Leaseback

    ***

  • Limitation on Subsidiary Debt

    ***

  • Limitation on layering (anti-layering)

    ***

  • Limitations on transactions with affiliates

    ***

  • Merger Restrictions

    ***

  • Others

    ***

  • Rating Trigger

    ***

Additional information

***

Latest issues

Show all

News

09/03/2023 Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023
28/02/2023 Bristol Myers Squibb: Other Events
02/02/2023 Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
02/02/2023 Bristol Myers Squibb: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
29/01/2023 Bristol Myers Squibb: Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers, Financial Statements And Exhibits
All organization news

IFRS/US GAAP reports

2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Identifiers

  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DBFSGR
  • FIGI
    BBG0000FDZ76
  • WKN
    A0G2EL
  • SEDOL
    B1HLYY4
  • Ticker
    BMY 5.875 11/15/36
  • Type of security by CBR
    ***

Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Trace-eligible
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
Show more Hide

Restructuring

***

Holders

Registration is required to get access.